Based on the study Bergonti et al. 12 and other recent publications 7, 14, 15 the flow chart
summarizes a possible role for an ILR and EPS in the risk stratification of Brugada patients …

Background This study aimed to investigate the characteristics and outcomes of patients
diagnosed with Brugada syndrome (BrS) who underwent implantable loop recorder (ILR) …

Aims To analyse the follow-up data of implantable cardioverter-defibrillator (ICD) therapy in
Brugada syndrome (BS). Methods and results We conducted a retrospective, single centre …

Dear Editor, We read with great interest the report of Sakhi et al.[1] on the outcome of
symptomatic patients with Brugada syndrome (BrS) and implantation of an insertable loop …

Objectives: The PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE)
prospective registry was designed to assess the predictive accuracy of sustained ventricular …

Background: Risk stratification in patients with Brugada syndrome for primary prevention of
sudden cardiac death is still an unsettled issue. A recent consensus statement suggested …

Abstract Background Risk stratification in Brugada syndrome (BrS) remains controversial. In
this respect, the role of the electrophysiology study (EPS) has been a subject of debate. In …

Background—Implantable cardioverter-defibrillator indications in Brugada syndrome remain
controversial, especially in asymptomatic patients. Previous outcome data are limited by …

Introduction: There is limited data on the experience with insertable cardiac monitors (ICMs)
in patients with Brugada syndrome. Objective: To evaluate the outcome of ICM in …

Brugada syndrome is an inherited cardiac arrhythmia disorder caused in about one-third of
patients by mutations in the cardiac channel genes, mainly SCN5A. Patients may develop a …